Postbiotics as Antiinflammatory and Immune‐Modulating Bioactive Compounds in Metabolic Dysfunction‐Associated Steatotic Liver Disease
2024
Postbiotics for Liver Health
publication
10 minutes
Evidence: moderate
Author Information
Author(s): Yilmaz Yusuf
Primary Institution: Recep Tayyip Erdoğan University
Hypothesis
Can postbiotics serve as effective therapeutic agents for metabolic dysfunction-associated steatotic liver disease (MASLD)?
Conclusion
Postbiotics show promise in treating MASLD by reducing inflammation, improving lipid metabolism, and enhancing gut health.
Supporting Evidence
- Postbiotics can reduce liver inflammation and improve gut health.
- These compounds may help in managing metabolic dysfunction associated with liver disease.
- Postbiotics have a better safety profile compared to probiotics.
Takeaway
Postbiotics are good things made by bacteria that can help keep our liver healthy and reduce sickness.
Methodology
This review summarizes various postbiotics and their effects on MASLD based on preclinical studies and literature.
Limitations
Current findings are primarily based on preclinical studies, which may not fully represent human conditions.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website